Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

16.64 USD +0.26 (+1.59%)
Streaming Delayed Price Updated: 10:26 AM EDT, Sep 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 57,280
Open 16.44
Bid (Size) 16.62 (1)
Ask (Size) 16.66 (2)
Prev. Close 16.38
Today's Range 16.37 - 16.75
52wk Range 11.81 - 28.20
Shares Outstanding 84,757,551
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases
Atara Biotherapeutics to Participate in a Panel Discussion at the Citi 16th Annual BioPharma Virtual Conference
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and... 
From Business Wire News Releases

Performance

YTD
-15.27%
-15.27%
1 Month
+22.80%
+22.80%
3 Month
+6.60%
+6.60%
6 Month
+12.43%
+12.43%
1 Year
+12.20%
+12.20%

More News

Read More
Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress
From Business Wire News Releases
Atara Biotherapeutics Appoints Cell Therapy and Oncology Commercialization Veteran Ameet Mallik to the Board of Directors
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Atara Biotherapeutics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
From Business Wire News Releases
Noteworthy ETF Outflows: LABU, ARNA, ARWR, ATRA
Tags ETFs
From ETF Channel
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
From Business Wire News Releases
Understanding Atara Biotherapeutics's Unusual Options Activity
Tags Benzinga Market News Movers
From Benzinga
The Math Shows VTWV Can Go To $164
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.